Synthesis, Characterization and Antitumour
Activity of Metal Complexes of 5-Carboxy-2-Thiouracil by Singh, Udai P. et al.
SYNTHESIS, CHARACTERIZATION
METAL COMPLEXES OF
AND ANTITUMOUR ACTIVITY
5-CARBOXY-2-THIOURACIL
Udai P. Singh.1 Sudha Singh2a and Sukh Mahendra Singh2b
Department of Chemistry, University of Roorkee, Roorkee-247 667 (U.P.), India
2a Department of Chemistry 2b School of Biotechnology
Banaras Hindu University, Varanasi-221 005, India
OF
Abstract
Metal complexes of 5-carboxy-2-thiouracil with Mn(ll), Co(ll), Ni(ll), Cu(ll), Zn(ll) and Cd(ll) ions were synthesized,
characterized, and subjected to a screening system for evaluation of antitumour activity against Sarcoma-180
(S-180) tumour cells. The complexes were characterized by elemental analysis, infrared, electronic spectra, room
temperature magnetic measurements and powder X-ray diffraction. The antitumour activity results indicate that
some complexes have antitumour activity both in v_jx andj_q vitro against S- 180 tumour cells.
Introduction
5-Carboxy-2-thiouracil (5CTU) (Fig. 1) containing nitrogen, sulphur and oxygen as donor atoms, plays an important
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Figure 1: 5-Carboxy-2-thiouracil
role in anticancer and antiviral activities [1]. The bacteriostatic or bacteriocidal activities of 5CTU and scanty
information on its metal complexes [2] as antitumour agent encouraged to undertake a systematic study of its
metal complexes and to test the antitumour activity of synthesized compounds. The present paper describes the
structural as well as the antitumour activity studies of Mn(II),Co(II), Ni(II), Cu(ll), Zn(ll) and Cd(ll) complexes
with 5CTU.
Results and Discussion
The satisfactory elemental analyses have been obtained for all compounds. They display 1:1 stoichiometry. All
the complexes are coloured except Zn(ll) and Cd(ll). They are insoluble in almost all common organic solvents
except Mn(II) complex which is sparingly soluble in dimethylsulfoxide on heating.
Infrared spectra
Table 1 shows some important infrared absorption bands of 5CTU and its complexes. Complexation can be
expected to lead the shifts in the carboxylate, thioamide and amide band positions in the spectra of the complexes.
The characteristic bands of the coordinated water molecule are present in the lower region of the spectra. The
position of v(fOO)asym (1660 cm1) and v(fOO)sym (|450 cm"1) bands are shifted after complexation. The shift of
v(COO)asym band towards higher wave numbers and v(COO)sym band towards lower wave numbers suggest the
unsymmetrical bonding of the carboxylate group and it acts as monodentate ligand towards one metal ion. The
thioamide bands also show shifting in the spectra of complexes whereas SNI-H, SN3-H bands do not exhibit any
shift suggesting that N-H and N3-H groups do not interact with metal ions.
Thus the binding of 5CTU with metal ions is suggested through CO0 and C=S groups which have been confirmed
on the basis of the presence of vM-0 and vM-S bands in the lower region of spectra [3].
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Table Infrared spectral data of 5CTU and its complexes
Band 5CTU Mn(lI) Co(H)
assignment
Ni(II) Cu(II) Zn(II) Cd(II)
vO-H
vN-H
vC=O,vC--C
v(COO)y
v C=S
8N()-H
v(coo)sym
8N3FH
vM-Oaquo
vM-S
vM-O
3470w 3M0w
3130m 3150m 3145m,b
1708s 1735s 1730s
1690s 1710w 1708m
1660s 1690s 1695s
1565s 1585m 1584s
1175s 1205s 1205s
1155w
1505w 1502m 1500s
1450s 1410s 1420s
1408s 1405s 1418s
375w 430m
267m 264m
235w 240w
M80m 3375w 3380w 3310w
3080w 3120w 3120w 3120w
1732m 1730s 1735s 1738s
1712m 1710w 1710w 1658w
1700m 1685s 1690m 1705s
1580m 1585rr. 1580w 1582s
1205s 1208m 1210s 1195s
1195w 1185w
1502rn 1502s 1505n 1502m
1415s 1405s 1425m 1408s
1412s 1420w 1408w 1405w
405m,b 468s 376w 350w
267m 265m 266m 267m
238w 230w 240w 235w
The infrared spectra of the complexes show bands at 1410, 1310, 1030 and 820cm -t in Mn(II)-5CTU; at 1438, 1295,
1020 and 815 cmt in Co(II)-5CTU; at 1400, 1310, 1039 and 820 cm1 in Ni(II)-5CTU; at 1390, 1320, 1040 and
824cm4 in Cu(II)-5CTU; at 1410, 1310, 1043 and 820cmt in Zn(II)-5CTU and at 1410, 1316, 1042 and 820cmt in
Cd(II)-5CTU complexes which confirm the monodentate behaviour of coordinated nitrate [4].
Electronic spectra and Magnetic moment
The magnetic moment ofMn (II)-5CTUcomplex is 5.75 B.M. and its electronic spectrum exhibits bands at 357 nm,
375nm and 460 nm which correspond to 6All
---) nA t_ (F), 6Alg ’1I’2 (D) and 6Alg 4Ate, 4Ed(G) transitions
respectively in an idealized octahedral geometry [5,6. The spectrumo Co(ll) compound is characterized by two
main bands at 415 nm and 895 nm which may be assigned to 4Ttg (F)---) nT.(P) and Ttg(F) Tzg(F) transitions
respectively. The band due to ’*Tg(F)-- 4Azg (F) transitions appeared at 220 nm. The magnetic momen! 4.80
B.M. is within the limits of the octahedral region for Co(II) compound [7]. The magnetic moment for Ni(II)-5CTU
complex is 3.59 B.M., the occurrence of d-d transition bands at 444 nm 3A.. (F)---> 3T. (P), 580 nm 3A2g(F)
3 3 zg g 3Try(F) and at 900nm Azg(F)--- Tz(F) in the spectrum of Ni(II) complex can be attributed to an octahedral
geometry for the Ni(II) complex [8]. Cu(II)-5CTU compound shows magnetic moment value 1.88 B.M., a distorted
octahedral structure is suggested. The electronic spectrum is characterized by a band at 720 nm which may be
due to ZE ---Tg(D) transition [6]
Powder X-ray diffraction studies
X-ray diffraction data (not shown) of the complexes were indexed according to the method of Ito [9]. The
indexing pattern yields lattice constants a=l 4.35,b=4.58 and c=3.53/ for Co(II)-5CTU: a=l 4.39, b=5.05 and
c=4.81/ for Ni(II)-SCTU; a=8.61, b=6.55 and c=3.80 A for Cu(II)-SCTU; a=l 4.56, b=5.04 and c=4.87/ for Zn(II)-
5CTU; a=8.46, b=6.36 and c=5.26/ for Cd(II)-SCTU and suggest orthorhombic symmetry for all these complexes
while Mn(II)-fCTU complex is amorphous.
On the basis of above studies, the structure of the complexes may be proposed as below"
M(II)=Mn(II), Co(II), Ni(II), Cu(II), Zn(II) mad Cd(II)
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Antitumour activity against Sarcoma-180
The ligand 5CTU has the antitumour activity with T/C value 115 at the dose of 25.0 mg/kg body weight. Among
the transition metal complexes only Co(H), Ni(II) and Cu(II) complexes have significant antitumour activity (Table
2). With Co(II)-SCTU and Cu(II)-SCTU treatment at the dose of 12.5 and 25.0 mg/kgbody weight respectively all
mice survived beyond six months.
Further it was found that none of the test compounds were toxic up to the dose of 50.0 mg/kg body weight except
the complex containing Cd(II) ion (as observed by body weight change upt to six days of drug treatment). The
compound Cd(II)-5CTU was found to be toxic even at the dose of 2.5 mg/kg body weight.
Table 2 In v_jy_Q antitumour activities of5CTU and its metal complexes against Sarcoma-180
Compounds
5CTU
Mn(5CTU)(NO3).3HzO
Co(5CTU) (NOa).3H20
Ni(5CTU) (NO).3H20
Cu(5CTU) (NO3).3HzO
Zn(5CTU) (NOa).3H20
Cd(5CTU) (NOa).3HzO
Dosage ip Mean life No. of
injection span of non- mice
mg/kg body survivors surviving
weighte T/Ca >6 monthsb
T/C%
12.5 32/40 80.0
25.0 46/40 115.0
12.5 40/40 100.0
25.0 26/40 65.0
12.5 All alive 6 (100)
25.0 32/40 80.0
12.5 48/40 120.0
25.0 34/40 85.0
12.5 38/40 95.0
25.0 All alive 6(100)
12.5 36/40 90.0
25.0 30/40 75.0
12.5 2/40 5.0
25.0 2/40 5.0
In each set of experiment six mice were used. T/C 6/6, T= tumoured, C control. (a) in calculating average
survival time mice surviving >6 months were not included. (b) number of parenthesis indicates percentage of
mice surviving six months or more. (c) single injection of the reported dose was given.
The ligand 5CTU and its complexes were also tested for their inhibitory effect on 3H-thymidine,3H-uridine and
3H-leucine incorporation in S-180 tumour cells in vitro. Most of the compounds that caused inhibition of 3H-
thymidine, 3H-uridine and 3H-leucine incorporation in S-180 tumour cells, also showed antitumour activity i___o_n
v_ix.o_ (Table 3a, 3b, 3c).
Table 3a. Percentage inhibition of 3H-thymidine incorporation in tumour cells in vitro *
Compound
Dose
5 gg/ml 10gg/ml 20 gg/ml
Co(SCTU) (NO3).3I-IO
Ni(5CTU) (NO3).3HO
Cu(SCTU) (NO3).3HO
37 18
15 77 84
21 50 68
Thus it is concluded from the resluts obtained in the present study that all the complexes have octahedral
structure. Regarding the antitumour activity study, the ligand 5CTU and its complexes with Co(II), Ni(II) and
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Table 3b. Percentage inhibition of 3H-uridine incorporation in tumour cells in vitro *
Dose
Compound
5 ktg/ml 101Ltg/ml 20 ktg/ml
Co(5CTU) (NO3).3H20
Ni(5CTU) (NO3).3I-IzO
Cu(SCTU) (NO3).3H20
20 21 45
32 28 21
Table 3c. Percentage inhibition of 3H-leucine incorporation in tumour cells in vitro *
Compound
Dose
5 l.tg/ml 101.tg/ml 20 ILtg/ml
Co(SCTU) ( O3).3I-I20
Ni(SCTU) (NO3).3H20
Cu(5CTU) (NO3).3HzO
* Tfiese tables show the results obtained for the compounds which show significant inhibition.
Cu(II) ions have antitumour activity. The mechanism of antitumour action of these compounds is not well
known. It is propable from the results obtained in the present study that these compounds may be effective
antitumour agents due to their inhibitory action on the replication of DNA, synthesis of RNA and protein in
tumour cells.
Experimental
Method of Synthesis
lmmole of hydrated metal nitrates were dissolved in a mixture of 35ml ethylalcohol and 15 ml triethylorthoformate
by refluxing for about 10hrs. Then, lm mole of 5CTU was added and the resultant mixture was refluxed for 20-25
days after which the volume of the reaction mixture was reduced to about one third of its original volume and the
precipitation was initiated by adding ether. The solid complexes were separated by filtration, washed several
times with ethanol, finally with ether and dried at 50o55c.
The metal ions were determined volumetrically after dissolving the complexes in dilute nitric acid 10]. Carbon,
hydrogen, and nitrogen were analyzed with a Perkin-Elmer model 240C elemental analyzer. The infrared spectra
were obtained inNujol on a Perkin-Elmermodel 783 spectrophotometer in the 4000-200cm-1 region. The electronic
spectra of the complexes were recorded in Nujol with a UV/VIS-168A Shimadzu spectrophotometer at room
temperature. The room temperature (298K) magnetic susceptibility measurements were made on Cahn Faraday
magnetic susceptibility balance. X-ray powder diffraction data of the complexes were obtained on a Philips X-ray
diffractometerPW1710 using CuKct radiation. Indexing of X-ray powder lines was done by Ito’s method [9].
Antitumour activity of the ligand5CTU and its synthesized metal complexes were tested against Sarcoma-180 (S-
180) tumour system both in vivo and in vitro according to the method described earlier [11]. Therapeutic
effectiveness of each compound against tumour bearing mice was assessed from the T/C percentage which was
calculated as follows:
Mean life span of treated mice*
T/C%
Mean life span of untreated mice
* excluding tumour free survivors.
X 100
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A T/C value of 115 indicates significant activity whereas > 125 indicates that complex is worthy of testing in
other tumour systems [12].
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